Targeting Nicotinic Receptors for Parkinson's Disease Therapy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
10
Page:
651-658
Author(s):
Maryka Quik, Tanuja Bordia, Luping Huang and Xiomara Perez
An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
10
Page:
659-669
Author(s):
Antoni Vallano, Víctor Fernandez-Duenas, Consuelo Pedros, Josep Maria Arnau and Francisco Ciruela
Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
10
Page:
693-702
Author(s):
Oscar Arias-Carrion, Sergio Machado, Flavia Paes, Bruna Velasques, Silmar Teixeira, Lizbeth Cardenas-Morales, Roberto Piedade, Pedro Ribeiro and Antonio E. Nardi
Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS): A Critical Review
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
10
Page:
757-761
Author(s):
Chiara Zecca and Claudio Gobbi
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
5
Page:
192-196
Author(s):
Pawel Bodera and Wanda Stankiewicz
Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Journal:
Drug Delivery Letters
Volume:
1
Page:
13-23
Author(s):
Andreas M. Grabrucker, Magali Rowan and Craig C. Garner
Therapeutic Advances in the Treatment of Alzheimer's Disease: Present and Future
Journal:
Current Drug Therapy
Volume:
6
Page:
175-185
Author(s):
Priti Jain and Hemant R. Jadhav
Pharmacological Approaches of Alzheimer's Disease: An Update
Journal:
Current Drug Therapy
Volume:
6
Page:
186-196
Author(s):
Safia A. Khan, Kamsagara L. Krishna, Ajay J. Parikh, Priya and Sudha R. Dodi
Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases
Journal:
Current Drug Therapy
Volume:
6
Page:
197-206
Author(s):
Keiichi Kadoyama, Kaori Kadoyama, Hiroshi Funakoshi, Toshikazu Nakamura and Toshiyuki Sakaeda
The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
3306-3313
Author(s):
B. Ray, N. B. Chauhan and D. K. Lahiri